jacobohincapiemd @jacohincapiemd

GI oncologist, Geriatric oncologist @OrlandoHealth. U.Florida & Harvard Med trained. 🇨🇴 - 🇺🇸, Proud father of a UF gator. Coffee entrepreneur Joined June 2021

Tweets

80
Followers

100
Following

457
Likes

588

OncoAlert @OncoAlert

11 months ago

The @OncoAlert 🚨Newsletter NOW OUT Covering September October 4-10, 2024 REGISTER AT Oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… Discussing: ✅Industry update💊: Phase 3 KEYNOTE-689🔑H&N ✅ #BreastCancer stats 2024🇺🇸 @CACancerJournal ✅high costs of…

1 17 35 30K 4

Download Video

OncLive.com @OncLive

11 months ago

The risk of death following disease relapse was significantly higher among non-Hispanic Black vs White children, indicating inequities in post-relapse care. @RLRandallMD @JNCI_Now @UCD_Cancer #oncology onclive.com/view/non-hispa…

0 1 0 933 0

Arndt Vogel @ArndtVogel

2 years ago

Radiological diagnosis of HCC does not preclude biopsy before treatment @JHEP_Reports doi.org/10.1016/j.jhep… 🔎167 pts 👉50% of poorly differentiated HCC not classified as LR-5 👉11% of LR-5 cases misqualified, incl. CRC & BTC cases 🧐Biopsy is 🗝️in the era of precision…

5 58 136 16K 34

Download Image

OncLive.com @OncLive

2 years ago

According to findings from the first interim analysis of the observational BESPOKE study, MRD detection by ctDNA was predictive of disease recurrence and response to adjuvant chemotherapy in pts with CRC. @pashtoonkasi #crcsm #GI24 onclive.com/view/ctdna-is-…

1 7 11 3K 0

Download Image

OncLive.com @OncLive

2 years ago

Fostrox/Lenvatinib Combination Displays Efficacy, Tolerability in Pretreated HCC @ASCO #GI24 #oncology #HCC onclive.com/view/fostrox-l…

0 1 0 770 0

Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM @agingdoc1

2 years ago

wix.to/1Et6H7x

0 1 2 631 0

Download Image

#TumorBoardTuesday @TumorBoardTues

2 years ago

1/7 🧵#TumorBoardTuesday EGJ/Gastric cancer treatment is increasingly driven by BIOMARKERS. Targeting Claudin18.2 coming soon. What do GI oncologists need to know? Check out the case wrap: @CowzerDarren @KlempnerSam review latest info on Claudin 🎯 #GastricCancer #EGJ

1 19 52 12K 7

Download Image

jacobohincapiemd @jacohincapiemd

2 years ago

Eliminate ABIMs MOC requirement - Sign the Petition! chng.it/7cfWH9mP via @Change

0 0 0 40 0

UF Hematology/Oncology Fellowship @HemeOncGators

2 years ago

As we enter fellowship interview season, we’ll be sharing all the reasons it’s so GREAT to be a Gator! Here are just a few to get us started! 🐊🎉

2 7 26 5K 0

Download Image

jacobohincapiemd @jacohincapiemd

2 years ago

The effect of fasting or calorie restriction on autophagy induction: A... sciencedirect.com/science/articl…

0 0 0 48 0

jacobohincapiemd @jacohincapiemd

2 years ago

Eng: No benefit of primary tumor resection in metastatic colon cancer. Esp: No hay beneficio en resección de tumor primario en cancer de colon metastasico

Manju George MVSc PhD Rectal Cancer Survivor @manjuggm

2 years ago

Eng: No benefit of primary tumor resection in metastatic colon cancer. Esp: No hay beneficio en resección de tumor primario en cancer de colon metastasico

2 1 3 640 1

Download Image

0 1 1 113 0

Arndt Vogel @ArndtVogel

2 years ago

Great discussion by John Strickler on FIRE-4 & PARADGIM @ #ASCO2023 Optimizing anti-EGFR directed therapy for #CRC @myESMO @OncoAlert

0 8 17 3K 3

Download Image

OncLive.com @OncLive

3 years ago

Successful manipulation of the immune system to achieve regression of cancer, long an unfulfilled goal of oncologic investigation, is an ever-increasing reality in multiple clinical settings. @DrMaurieMarkman #oncology ow.ly/HvR950N2T8J

0 1 2 736 0

OncLive.com @OncLive

3 years ago

.@RamnaraignMD, of @UFHealthCancer, discusses the investigation of atezolizumab with tivozanib in castrate-resistant prostate cancer. #pcsm ow.ly/K0Ex50MYtPo

0 3 5 4K 0

OncLive.com @OncLive

3 years ago

Talazoparib Plus Enzalutamide Improves rPFS in First-line mCRPC @neerajaiims @Ecastromarcos @huntsmancancer @ASCO #pcsm #GU22 ow.ly/mMvc50MUShr

0 3 1 650 0

OncLive.com @OncLive

3 years ago

SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab demonstrated early evidence of efficacy in patients w/ metastatic pancreatic ductal adenocarcinoma, according to updated results from the phase 1 SGNS40-001 study. @fredhutch #pancsm ow.ly/hERp50MQ3qb

0 2 1 1K 1

Oncology Brothers @OncBrothers

3 years ago

Day 3 #GI23 Highlights #CommunityOncology 1. #MOUNTAINEER: Tucat+Trast approved CRC 2. #SUNLIGHT: TAS102+Bev confirmed late option CRC 3. #E2211: Cape+Tem in pNET manuscript 4. #ctDNA kinetics CRC 5. TNT state in RectalCA @ASCO #OncEd #MedEd @OncoAlert #GISM #MedTwitter

2 61 141 34K 20

jacobohincapiemd @jacohincapiemd

3 years ago

The best of these conferences is catching up with wonderful GI oncologist, incredible mentors and great friends like @SheRiseRogersMD #GIASCO23 @UFHealthCancer UF gators forever

0 1 6 781 0

Download Image

jacobohincapiemd @jacohincapiemd

3 years ago

The power of perseverance Colombian GI oncologist 🇺🇸 🇨🇴

Arturo LoAIza-Bonilla, MD MSEd @DrBonillaOnc

3 years ago

The power of perseverance Colombian GI oncologist 🇺🇸 🇨🇴

2 1 35 3K 0

Download Image

0 0 6 172 0

OncLive.com @OncLive

3 years ago

Happy first day of @ASCO #GI23! OncLive is on site and ready to see what this year’s symposium has in store. Follow along to see which experts we talk to and what abstracts we highlight- and if you’re in person, don’t forget to stop by!! #oncology